Suprainguinal Fascia Iliaca Block in Knee Arthroplasty

NCT06386575 | Completed

• 1 other identifier: suprainguinal
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Total knee arthroplasty is the most commonly performed orthopedic surgery, especially in patients with advanced gonarthrosis and limited joint movement. After total knee arthroplasty, patients experience unbearably severe pain. Pain that is not adequately treated in the postoperative period increases the stress response in patients, increases the risk of embolism, causes bleeding in the surgical area, and causes undesirable conditions such as agitation and delirium in patients. This postoperative pain is successfully treated with various variants of multimodal analgesia.

Conditions

Analgesia; Anesthesia, Local

Outcome Measures

Primary Outcomes (1)

• quality of recovery-15T

  Quality of recovery-15T scores, which show the quality of recovery of the patients, will be recorded at the 24th hour after the surgery. Quality of recovery-15T (0-150, 0= lowest degree of satisfaction, 150= highest degree of satisfaction).

  One day

Study Arms (2)

control group

OTHER

Other: control group; Patients who received physiological saline

suprainguinal fascia iliaca block

ACTIVE COMPARATOR

Other: suprainguinal fascia block; Patients receiving local anesthetic

Interventions

control group; Patients who received physiological saline OTHER

All patients will be given 1 gram of paracetamol intravenously + 20 milligrams of tenoxicam + 8 milligrams of decort intravenously. Paracetamol 3x1 gram + tenoxicam 2x20 milligrams will continue to be administered. Patients in the control group will be given 40 milliliters of physiological saline during the suprainguinal fascia iliaca block.

control group

suprainguinal fascia block; Patients receiving local anesthetic OTHER

All patients will be given 1 gram of paracetamol intravenously + 20 milligrams of tenoxicam + 8 milligrams of decort intravenously. Paracetamol 3x1 gram + tenoxicam 2x20 milligrams will continue to be administered. Patients in the sfıb group will be given 40 milliliters of 0.25 % bupivacaine during the suprainguinal fascia iliaca block.

suprainguinal fascia iliaca block

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients who will undergo unilateral total knee arthroplasty
• Patients who will undergo spinal anesthesia
• Patients aged 18-65 years, ASA I-III
• Patients who will stay in the hospital for at least 24 hours

You may not qualify if:

• Patients who do not want to give consent
• Patients who do not want spinal anesthesia
• Patients for whom regional anesthesia is contraindicated
• Patients with confusion
• Patients with coagulopathy
• Patients using anticoagulants
• Patients with infection in the area to be treated
• Those who are allergic to local anesthesia
• Emergency cases

Sponsors & Collaborators

• Konya City Hospital: lead

Study Sites (1)

Konya City Hospital

Konya, 42020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Agnosia

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Specialist, Department of Anesthesiology, Konya City Hospital, M.D

Model Details: Suprainguinal fascia iliaca block will be applied to the patients at the end of the surgery.

Study Record Dates

• First Submitted: April 15, 2024
• First Posted: April 26, 2024
• Study Start: June 6, 2024
• Primary Completion: August 1, 2024
• Study Completion: August 3, 2024
• Last Updated: August 6, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)